CD2 CJC With DAC | Peptide CAS 796043-06-6 Jack
8 Inquiries
796043-06-6
Pharmaceutical
99%
HongKong
HUATAI
10vials
2026-11-02
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionResearch & Reference Note
CD2 CJC With DAC | Peptide CAS 796043-06-6 Jack is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
NA
CAS No.:796043-06-6
Molecular Formula:C21H30N2O6S
Molecular Weight:438.54
Categories:
Characteristics-
Density:
1.373±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
Boiling Point:605.408±63.00 °C(Press: 760.00 Torr)(predicted)
PKA:14.773±0.10(predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Location:
1502A1, Building 4, Xinyuanxin Center, No. 3 Huaxin Road, Dongfeng Street, Licheng District, Jinan City, Shandong Province
-
Payment Terms:
TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
1
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
Certifications:
COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA
-
-
Inquiry History8 Inquiries
Country Product Purchase Quantity Date Posted
United States
Retatrutide 10mg Retatrutide 10mg
10 MT May 16, 2026
United States
Peptide
1 MT Feb 13, 2026
United States
Peptide
100 Jan 28, 2026
United States
Retatrutide 10 mg
10 MG Mar 4, 2026
Hongkong, China
Peptide
10000 MT Jan 6, 2026
Ireland
retatrutide 10mg
10 Mar 27, 2026
Canada
Peptide
10 G Mar 1, 2026
Canada
Peptide
1 MT Feb 24, 2026 Post an enquiry for this product